Gonzalo Merino, Ph.D., J.D., joined Regeneron in 2013 and now serves as senior vice president and chief intellectual property counsel. from the University of Rochester and a Ph.D. from State University of New York. You may also find the annual proxy statement by going directly to the company's website. Dr. Hughes worked for Sunovion Pharmaceuticals, FORUM Pharmaceuticals, and spent 14 years at Pfizer, where she held various roles of increasing responsibility. The total cash compensation, which includes bonus, and annual incentives, can vary anywhere from $240,390 to $295,690 with the average total cash compensation of $262,090. BMS Prior to joining J&J, Christina worked in financial and corporate communications for Biogen and at Boehringer Ingelheim in various pharmaceutical sales and communications roles. He served as chairman of the board from 1990 through 1994. in biology from the University of Massachusetts. Glassdoor provides our best prediction for total pay in today's job market, along with other types of pay like cash bonuses, stock bonuses, profit sharing, sales commissions, and tips. Mr. OLeary received his B.S. She has been the chair of the Department of Molecular Biology and the Squibb Professor in Molecular Biology at Princeton University since 2003 and is a Howard Hughes Medical Institute investigator. Aidez-nous protger Glassdoor en confirmant que vous tes une personne relle. pour nous faire part du problme. Average salary for AstraZeneca Vice President Finance in Burton Latimer, England: [salary]. los inconvenientes que esto te pueda causar. Regeneron is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion or belief (or lack thereof), sex,. Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for treating various medical conditions worldwide. The Role Reporting to the company's CEO/CFO, the Vice President of Finance, Controller is a VP-level manager who leads the company's accounting and financial reporting functions and sits on the six OpenGov - San Jose Stocks. He previously served as the regional CFO for Japan, Australia and New Zealand at Mylan, as well as other roles, and he worked at Cephalon in financial roles. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema (DME); myopic choroidal neovascularization; and diabetic retinopathy in patients with DME, as well as macular edema following retinal vein occlusion, including macular edema following central retinal vein occlusion and macular edema following branch retinal vein occlusion. Drs. He also is a member of the boards of trustees of The Rockefeller University and the Howard Hughes Medical Institute. from the University of Navarra, completed a fellowship in immunology/pulmonary and critical care at Yale University, received an MPH. The total cash compensation, which includes bonus, and annual incentives, can vary anywhere from $427,990 to $618,190 with the average total cash compensation of $507,290. Ms. McCourt began her career and spent 12 years at AstraZeneca, ultimately becoming chief operating officer for AstraZeneca U.S. She received her B.S. Regeneron Pharmaceuticals: Delivering Life-transforming Medicines Push the bounds of science Make life-changing medicines Pause Regeneron News: Feb 23rd Aflibercept 8 mg BLA for Treatment of Wet Age-Related Macular Degeneration and Diabetic Macular Edema Accepted for FDA Priority Review Follow us: Now approved for a new indication Now approved for Mr. Brooks received both a B.S. Prior to joining Regeneron, Dr. Morton completed post-doctoral fellowships at Pfizer and Sloan Kettering Cancer Center. Glassdoor has salaries, wages, tips, bonuses, and hourly pay based upon employee reports and estimates. She is a member of the National Academy of Sciences, the National Academy of Medicine, the American Academy of Arts and Sciences, the Royal Society of London and the American Philosophical Society. Be the first to add REGENERON PHARMACEUTICALS, INC. Vice President of Human Resources responsibilities. She serves on the boards of directors of Prudential Financial, Inc. and the Sherwin-Williams Company. Prior to BOL, he spent 12 years at AstraZeneca/MedImmune in roles of increasing responsibility, ultimately building and overseeing the cardiovascular renal and metabolism clinical therapeutic area at MedImmune. She has received many scientific honors, including a MacArthur Foundation Fellowship, the Lounsbery Award, the Shaw Prize for Life Science and Medicine, the Gruber Prize in Genetics and the Wolf Prize in Chemistry. in microbiology from Rutgers University and his Ph.D. in pharmacology/toxicology jointly from Rutgers and the University of Medicine and Dentistry of New Jersey, and has been board-certified in toxicology. Under Dr. Hughes leadership, Regenerons Pharmacovigilance and Risk Management function has evolved to global patient safety (GPS), and she has reorganized the safety function in a scalable manner, integrating science, operations and technology advancement to support Regenerons global pipeline, while aligning with the external regulatory landscape. from New York University. He has served as chief executive officer of GanD, Inc. since 2016, and chair of Grace Science, LLC since 2017. Richard (Rich) ONeal joined Regeneron in 2018 and is the senior vice president of market access. Find high paying available jobs at Regeneron Pharmaceuticals, Inc.For expert network information on Regeneron Pharmaceuticals, Inc compensation and careers, use Ladders $100K + Club. The estimated additional pay is $210,764 per year. from the United States Air Force Academy and her M.A. Bob McCowan is senior vice president and chief information officer at Regeneron. Of this total $724,500 was received as a salary, $819,410 was received as a bonus, $3,347,323 was received in stock options, $2,231,397 was awarded as stock and $24,200 came from other types of compensation. Mr. Prior to Inova, Ms. Paull was senior vice president, chief human resources ocer at Forest Laboratories. He has been the president of Stanford University since 2016. J&J Gilead Feb 1, 2023 11:58am. Caso continue recebendo esta mensagem, Based on 12 salaries posted anonymously by AstraZeneca Vice President Finance employees in Seaham, England. Bitte helfen Sie uns, Glassdoor zu schtzen, indem Sie besttigen, dass Sie REGENERON PHARMACEUTICALS, INC. income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. Sing has been a director of the company since 1988. envie um e-mail para Si continas recibiendo este mensaje, infrmanos del problema The estimated total pay for a Vice President Operations at Regeneron is $448,608 per year. He is responsible for protecting Regenerons intellectual property, including by developing and implementing a comprehensive global IP strategy. In addition to a robust portfolio of antibody therapeutics, she has been a company leader in the application of novel nucleotide and gene therapies. Prior to joining Regeneron, Ms. Ravetti spent 10 years at Pfizer in various positions of increasing responsibility, and she was previously an Associate at the law firm of Sullivan and Cromwell. Christina Chan joined Regeneron in 2021 and serves as senior vice president, corporate communications and citizenship, leading a multidisciplinary team responsible for external & internal communication, patient advocacy, corporate responsibility, ESG strategy & reporting, and social impact. Well-versed in leave administration The VP you'll be reporting to has a collaborative leadershipof Monday, February 13th. Thank you to our incredible colleagues for making this truly a great place to work and a place where passion meets opportunity. Frederick Austin joined Regeneron in 2012 and serves as senior vice president, quality control, Raheen. The lowest-paying job at Regeneron is a Research Assistant with a salary of $52,103 per year. The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Ms. Poon has been a director of the company since 2010. Dr. Tessier-Lavigne is also a member of the board of directors of Denali Therapeutics Inc. President Emeritus of Memorial SloanKettering Cancer Center. Bola Akinlade, M.D., FACP, joined Regeneron in 2015 and serves as senior vice president, clinical development for Regenerons immunology and inflammation (I&I) portfolio. Ms. Lozner oversees all aspects of Regenerons corporate compliance program. Andrew Murphy, Ph.D., joined Regeneron in 1999 as director of genomics and bioinformatics and is now executive vice president of research. Dr. Braunstein received his B.S. William Olson, Ph.D., joined Regeneron in 2013 as vice president and now serves as senior vice president of therapeutic proteins, where he is responsible for antibody generation, a key component of drug discovery, through innovative technologies. Senior Vice President, Technical Operations. Previously, he served as president of The Rockefeller University and Carson Family Professor and head of the Laboratory of Brain Development at The Rockefeller University from 2011 to 2016. Vice President of Operations yearly salaries in the United States at Regeneron Job Title Vice President of Operations Location United States Low confidence Estimated average pay $112,836 per year 23% Below national average Average $112,836 Low $104,937 High $126,376 L. Andres Sirulnik, M.D., Ph.D. joined Regeneron in 2020 and serves as senior vice president, translational & clinical sciences, hematology, leading strategic program direction and clinical sciences work for our early- and late-stage oncologic hematology and late-stage non-oncology hematology portfolios. verdade. Mr. McCowan previously worked at international organizations including Amgen, Artemis International, Computer Science Corporation and Lockheed. Total Compensation $8.8M. from Harvard Medical School. Abbott In her role, Dr. Morton has led the discovery and development of a highly innovative and diverse portfolio across disease areas. A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. and B.S. Senior Vice President, Global Development Quality & Regulatory Compliance. Mr. Calabro leads a team responsible for providing independent and objective assurance and consulting by bringing a systematic, disciplined approach to evaluating and improving the effectiveness of Regenerons risk management, control and governance processes. Earlier in her career, Ms. Paull served in progressively senior human resources roles at DENYSPLY International. The community relies on everyone sharing. Prior to joining Regeneron, Dr. DiCioccio spent 14 years with a biotechnology start-up, after previously working with Lederle Laboratories for 14 years. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema (DME); myopic choroidal neovascularization; and diabetic retinopathy in patients with DME, as well as macular edema following retinal vein occlusion, including macular edema following central retinal vein occlusion and macular edema following branch retinal vein occlusion. The base salary for Vice President of Human Resources in companies like REGENERON PHARMACEUTICALS, INC. range from $365,490 to $478,390 with the average base salary of $416,290. Previously, Dr. Geba worked at Sanofi, AstraZeneca, Novartis, Merck and Yale University as an assistant professor of medicine. Dr. Lin received his M.D. Se continui a visualizzare Christina holds an MBA in finance and strategy from the Stern School of Business at New York University and a B.A. , It is especially meaningful that this award is based in part on the quality and consistency of employee reviews on Glassdoor. Overall Benefits Rating.css-11cfy92{color:#0caa41 !important;}.css-11cfy92{color:#0caa41 !important;}4.1, Matches half of your contribution up to 5% (of gross pay) on 10%. This position will direct all areas of Human Resource administration including; recruiting, salary administration, associate services, associate benefits, management development/training and labor American Association of Motor Vehicles - Arlington This employer has claimed their Employer Profile and is engaged in the Glassdoor community. Dr. Weinreich also previously served as vice president of clinical affairs at Gene Logic and as an independent consultant, helping small- to mid-stage biotechnology companies with drug commercialization. He also previously served within the internal audit teams at Phillip Morris, General Foods and Bowater, Inc. Mr. Calabro received a B.S. He received his B.S. Related Searches:All Vice President Salaries|All Regeneron Salaries. He has held prior positions at Regeneron in quality control and analytical sciences, and prior to joining Regeneron, worked at Abbott Laboratories conducting diagnostic assay R&D, bio-process development and commercial assay kit manufacturing. Before joining Regeneron, he was at Progenics Pharmaceuticals for 19 years. Prior to joining the industry, Ms. Lozner was a litigation attorney and served as a law clerk for Hon. Dr. DiCioccio earned an B.S. Senior Vice President, Regeneron Genetics Center. in chemical engineering from the University of Nevada, Reno and his Ph.D. in chemical engineering from Iowa State University. Gary Herman, M.D., joined Regeneron in 2015 and leads the early clinical development and experimental sciences (ECDES) function. Prior to joining Regeneron, Ms. McCourt worked at Axovant, a clinical-stage biopharmaceutical company, where she was president and chief operating officer. Prior to joining Regeneron, Ms. Bermingham held roles of increasing responsibility at PhRMA over a 12 year tenure, following earlier positions at legal firms, and work for Senator Moynihan and the Senate Finance Committee. Average salaries for Regeneron Vice President: [salary]. In March, Christos Kyratsous, vice president for infectious disease research and viral vector technologies at Regeneron, told Vox that this treatment could also be used prophylactically to. Thorough reviews have been conducted to assure this data accurately reflects disclosures. Senior Vice President, IT and Chief Information Officer. COMPANY SIZE 5,000 to 9,999 employees INDUSTRY Biotechnology/Pharmaceuticals FOUNDED 1988 WEBSITE https://www.regeneron.com/ Similar Jobs Respiratory Therapist - PRN - Ardmore Mercy Ardmore, OK 11 days ago Apply RRT Focus Staff Ardmore, OK 8 days ago He holds a B.S. Dr. Sirulnik is a licensed physician, formerly practicing at Dana-Farber Cancer Institute and Brigham and Womens Hospital and was a fellow in hematology/oncology at Mount Sinai Health System. Amgen Mr. Ms. Gilooly has held positions of increasing responsibility in validation and quality assurance and operations. She previously led communication for the cardiovascular & metabolism therapeutic area and global commercial strategy organization at Janssen, J&Js pharmaceutical division. Mr. LaRosa received his J.D. Prior to joining Johnson & Johnson, Ms. Poon held senior leadership positions at Bristol-Myers Squibb Company, including president of international medicines and president of medical devices. Get a free, personalized salary estimate based on today's job market. Dr. Yancopoulos, together with key members of his team, is a principal inventor and/or developer of the nine FDA-approved drugs Regeneron has developed: EYLEA (aflibercept) Injection, Praluent (alirocumab), Dupixent (dupilumab), Kevzara (sarilumab), Libtayo (cemiplimab), EvkeezaTM (evinacumab-dgnb), Inmazeb (atoltivimab, maftivimab and odesivimab-ebgn), ZALTRAP (ziv-aflibercept) Injection for Intravenous Infusion, and ARCALYST (rilonacept) Injection for Subcutaneous Use, as well as Regeneron's foundation technologies, including the TRAP technology, VelociGene and VelocImmune. Regeneron Daniel Van Plew joined Regeneron in 2007 and has served as executive vice president and general manager, industrial operations and product supply since January 2016. He was also a professor at Stanford University from 2001 to 2003 and at the University of California, San Francisco from 1991 to 2001. Alessandra Ravetti, J.D., joined Regeneron in 2012 and serves as senior vice president, associate general counsel. Our company is built on breakthrough ideas; which is why we foster a spirit of.css-epvm6{white-space:nowrap;}.css-epvm6{white-space:nowrap;} More, Learn How to State Your Case and Earn Your Raise, Climb the Ladder With These Proven Promotion Tips, A Guide to Negotiating the Salary You Deserve, How to Prepare for Your Interview and Land the Job. RL . Abbvie John Calabro joined Regeneron in 2005 and serves as senior vice president, internal audit. He received his B.S. at the State University of New York at Albany and a J.D. ,